Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001454982-10-000099)

Filing Details

Accession Number:: 0001454982-10-000099
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-11-19 20:06:23
Reporting Period:: 2010-11-19

Filing Date:: 2010-11-19
Accepted Time:: 2010-11-19 20:06:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
881464	Amylin Pharmaceuticals Inc	AMLN	Pharmaceutical Preparations (2834)	330266089

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1493811	Christian Weyer	9360 Towne Centre Dr San Diego CA 92121	Svp, Research & Development	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-11-19	1,314	$13.42	3,357	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,815	Indirect	by ESOP

Footnotes

Direct holdings include 1,302 shares acquired on August 31, 2010 under the company's employee stock purchase plan.
Represents shares acquired pursuant to the Company's ESOP. These shares fully vest four years from the date of the reporting person's participation in the ESOP in four equal annual installments and are generally distributed upon termination of employment.